PRO103 The IMPACT of COVID-19 on the Future Pricing and Market Access of RARE Diseases and CELL-/GENE-Therapies

Detalles Bibliográficos
Autores principales: Teale, C., Roldan-Gomendio, A., Heinz, S., Sayadian, C., Jimenez, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631949/
http://dx.doi.org/10.1016/j.jval.2020.08.1839
_version_ 1784607661867663360
author Teale, C.
Roldan-Gomendio, A.
Heinz, S.
Sayadian, C.
Jimenez, N.
author_facet Teale, C.
Roldan-Gomendio, A.
Heinz, S.
Sayadian, C.
Jimenez, N.
author_sort Teale, C.
collection PubMed
description
format Online
Article
Text
id pubmed-8631949
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-86319492021-12-01 PRO103 The IMPACT of COVID-19 on the Future Pricing and Market Access of RARE Diseases and CELL-/GENE-Therapies Teale, C. Roldan-Gomendio, A. Heinz, S. Sayadian, C. Jimenez, N. Value Health Article Published by Elsevier Inc. 2020-12 2020-12-11 /pmc/articles/PMC8631949/ http://dx.doi.org/10.1016/j.jval.2020.08.1839 Text en Copyright © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Teale, C.
Roldan-Gomendio, A.
Heinz, S.
Sayadian, C.
Jimenez, N.
PRO103 The IMPACT of COVID-19 on the Future Pricing and Market Access of RARE Diseases and CELL-/GENE-Therapies
title PRO103 The IMPACT of COVID-19 on the Future Pricing and Market Access of RARE Diseases and CELL-/GENE-Therapies
title_full PRO103 The IMPACT of COVID-19 on the Future Pricing and Market Access of RARE Diseases and CELL-/GENE-Therapies
title_fullStr PRO103 The IMPACT of COVID-19 on the Future Pricing and Market Access of RARE Diseases and CELL-/GENE-Therapies
title_full_unstemmed PRO103 The IMPACT of COVID-19 on the Future Pricing and Market Access of RARE Diseases and CELL-/GENE-Therapies
title_short PRO103 The IMPACT of COVID-19 on the Future Pricing and Market Access of RARE Diseases and CELL-/GENE-Therapies
title_sort pro103 the impact of covid-19 on the future pricing and market access of rare diseases and cell-/gene-therapies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631949/
http://dx.doi.org/10.1016/j.jval.2020.08.1839
work_keys_str_mv AT tealec pro103theimpactofcovid19onthefuturepricingandmarketaccessofrarediseasesandcellgenetherapies
AT roldangomendioa pro103theimpactofcovid19onthefuturepricingandmarketaccessofrarediseasesandcellgenetherapies
AT heinzs pro103theimpactofcovid19onthefuturepricingandmarketaccessofrarediseasesandcellgenetherapies
AT sayadianc pro103theimpactofcovid19onthefuturepricingandmarketaccessofrarediseasesandcellgenetherapies
AT jimenezn pro103theimpactofcovid19onthefuturepricingandmarketaccessofrarediseasesandcellgenetherapies

Ejemplares similares